• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.08% Nasdaq Up0.22%

    Cytosorbents Corporation (CTSO)

    7.08 Up 0.15(2.16%) Nov 27, 12:58PM EST
    ProfileGet Profile for:
    Cytosorbents Corporation
    7 Deer Park Drive
    Suite K
    Monmouth Junction, NJ 08852
    United States - Map
    Phone: 732-329-8885
    Fax: 732-329-8650
    Website: http://www.cytosorbents.com

    Index Membership:N/A
    Industry:Medical Laboratories & Research
    Full Time Employees:50

    Business Summary 

    CytoSorbents Corporation, a critical care focused immunotherapy company, engages in the research, development, and commercialization of medical devices with its platform blood purification technology incorporating a proprietary adsorbent polymer technology. Its principal product is CytoSorb device, an extracorporeal cytokine filter designed for the adjunctive therapy in the treatment of sepsis; for the adjunctive therapy in other critical care applications; the prevention of post-operative complications of cardiopulmonary bypass surgery and damage to organs donated by brain-dead donors prior to organ harvest; the treatment of cancer cachexia; and the prevention of transfusion reactions caused by contaminants in transfused blood products; and the prevention of contrast induced nephropathy, the treatment of drug overdose, and the treatment of chronic kidney failure. The company is also developing HemoDefend blood purification technology platform to reduce contaminants in the blood supply that can cause transfusion reactions or disease when administering blood and blood products to patients; and ContrastSorb for the removal of IV contrast in blood administered during CT imaging, an angiogram, or during a vascular interventional radiology procedure to reduce the risk of contrast-induced nephropathy. In addition, it is developing BetaSorb device for the prevention and treatment of health complications caused by the accumulation of metabolic toxins in patients with chronic renal failure; and DrugSorb, an extracorporeal hemoperfusion cartridge designed to remove toxic chemicals from the blood. The company was formerly known as MedaSorb Technologies Corporation and changed its name to CytoSorbents Corporation in May 2010. CytoSorbents Corporation was founded in 1997 and is based in Monmouth Junction, New Jersey.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Cytosorbents Corporation

    Key Executives 
    Dr. Phillip P. Chan M.D., Ph.D., 45
    Chief Exec. Officer and Director
    Ms. Kathleen P. Bloch MBA, CPA, 60
    Chief Financial Officer and Sec.
    Mr. Vincent Capponi MS, 57
    Chief Operating Officer
    Dr. Robert Bartlett M.D., 76
    Chief Medical Officer and Member of Cardiac Surgery Advisory Board
    Dr. Christian Steiner M.D.,
    VP of Sales and Marketing
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders